Trump vows to slash drug prices and boost U.S. manufacturing, but tariffs and market realities may drive costs higher instead ...

The Trump administration has issued numerous pharma-focused executive orders, including “Lowering Drug Prices by Once Again Putting Americans ...

From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment ...

Gain insights from Humacyte's Q2 2025 earnings call, highlighting Symvess' commercial expansion, strategic pricing, pipeline progress, and ...

New York hospitals that get discounted drugs through a controversial federal program are gearing up for a new pilot that they ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

A normally hard-headed bench just endorsed President Biden’s scheme to dictate how much drugmakers can charge under Medicare.

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since their inception.

On August 1, 2025, the Health Resources and Services Administration (“HRSA”) issued a Notice announcing the launch of the 340B Rebate Model ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

Democratic Sens. Ron Wyden and Elizabeth Warren have asked to see internal company documents after a Guardian investigation alleged that the company partnered with nursing homes across the country to ...